Abstract
Gliomas are the most common primary malignant brain tumors, which have a universally fatal outcome. Current standard treatment for glioma patients is surgical removal followed by radiotherapy and adjuvant chemotherapy. Due to therapeutic resistance and tumor recurrence, efforts are ongoing to identify the molecules that are fundamental to regulate the tumor progression and provide additional methods for individual treatment of glioma patients.
By studying the initiation and maintenance of glioma, studies focused on the targets of tyrosine kinase receptors including EGFR, PDGFR and other crucial signal pathways such as PI3K/AKT and RAS/RAF/MAPK pathway. Furthermore, recent advances in targeting immunotherapy and stem cell therapy also brought numerous strategies to glioma treatment. This article reviewed the researches focused on the advanced strategies of various target therapies for improving the glioma treatment efficacy, and discussed the challenges and future directions for glioma therapy.Keywords: Glioma, clinical trials, targeted therapy, cell signal transduction pathway, glioma stem cell, Immunotherapy.
Related Journals
Recent Advances in Inflammation & Allergy Drug Discovery
Current HIV Research
Infectious Disorders - Drug Targets
Recent Advances in Anti-Infective Drug Discovery
Anti-Infective Agents
Current Pharmaceutical Design
Current Topics in Medicinal Chemistry
Coronaviruses
Current Probiotics
Endocrine, Metabolic & Immune Disorders - Drug Targets
Related Books
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in HIV Research
Frontiers in HIV Research
Anthrax: History, Biology, Global Distribution, Clinical Aspects, Immunology, and Molecular Biology
Antiprotozoal Drug Discovery: A Challenge That Remains
149
35
3
3